You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Patent: 10,155,932


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,155,932
Title:Decreasing potential iatrogenic risks associated with influenza vaccines
Abstract:Influenza viruses for use in preparing human vaccines have traditionally been grown on embryonated hen eggs, although more modern techniques grow the virus in mammalian cell culture e.g. on Vero, MDCK or PER.C6 cell lines. The inventor has realised that the conditions used for influenza virus culture can increase the risk that pathogens other than influenza virus may grow in the cell lines and have identified specific contamination risks. Suitable tests can thus be performed during manufacture in order to ensure safety and avoid iatrogenic infections.
Inventor(s):Gregersen Jens-Peter
Assignee:Novartis AG
Application Number:US15150214
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Claims and Patent Landscape of United States Patent 10,155,932

Introduction

Patents are a cornerstone of innovation, providing inventors with exclusive rights to their inventions in exchange for public disclosure. To analyze the claims and patent landscape of United States Patent 10,155,932, it is crucial to delve into the various components of a patent, the legal requirements for patentability, and the broader patent landscape.

Components of a Patent

A patent consists of several key components, each serving a specific purpose:

Cover Page and Abstract

The cover page includes essential information such as the patent number, the date the patent was issued, and an abstract that briefly summarizes the invention[1].

Drawings

Drawings illustrate the background technology, various aspects of the invention, and different implementations. These visual aids are crucial for understanding the invention's scope and application[1].

Specification

The specification is a detailed textual description of the invention. It must meet specific legal requirements, including written description, enablement, novelty, and nonobviousness. This section ensures that a person skilled in the relevant technology can make and use the invention[1].

Patent Claims

The patent claims define the legal boundaries of the invention and specify what the inventor regards as their invention. These claims are the most critical part of the patent, as they determine the scope of the patent right[1].

Legal Requirements for Patentability

For a patent to be valid, the invention must satisfy several legal requirements:

Written Description

The specification must adequately describe the invention, ensuring that the inventor has provided a clear and complete disclosure of the invention[1].

Enablement

The specification must enable a person skilled in the relevant technology to make and use the invention. This requirement ensures that the invention is not just described but can also be practically implemented[1].

Novelty

The invention must be new and not the same as something known in the prior art. This means that every element of the claimed invention must not be disclosed in the prior art before the effective filing date of the patent application[2].

Nonobviousness

The invention cannot be an obvious extension of the prior art. It must be significantly different from what is already known, ensuring that the invention represents a genuine advancement[2].

Patent Claims Analysis of 10,155,932

To analyze the claims of United States Patent 10,155,932, one must carefully review the patent claims section. Here are some key points to consider:

Claim Structure

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims, adding additional specificity to the invention[1].

Claim Scope

  • The claims should be clear and specific to define the scope of the patent right. Overly broad claims may be rejected for lack of novelty or nonobviousness.
  • The claims must be supported by the specification to ensure that they are enabled and described adequately[1].

Prior Art Analysis

  • Reviewing the prior art cited during the patent prosecution process can provide insights into why certain claims were allowed or rejected. This can be done by examining the patent file wrappers, which contain the examiner’s arguments and the applicant’s responses[5].

Patent Landscape Analysis

Geographical Distribution

  • Analyzing the geographical distribution of patents related to the same technology can highlight leading countries and organizations in the field. This can be particularly useful for understanding global trends and competitive landscapes[3].

Technological Milestones

  • Tracing key technological milestones through patent filings and citation analysis can provide a historical context of the innovation in the field. This helps in understanding the evolution of the technology and identifying key players[3].

Competitive Intelligence

  • Reviewing patent file wrappers and other patent documents can offer valuable competitive intelligence. It provides insights into the arguments made by examiners and the strategies employed by applicants to overcome rejections, which can be crucial for multi-million or billion-dollar investment decisions[5].

Enforcement and Litigation

Patent Infringement

  • The exclusive rights granted by a patent allow the owner to prevent others from making, using, importing, offering for sale, or selling the invention. However, the patent does not grant the owner the positive right to practice the invention if it infringes on another patent[1].

Patent Trial and Appeal Board (PTAB)

  • The PTAB, established by the Leahy-Smith America Invents Act (AIA), provides a faster and less expensive way to challenge patent validity compared to judicial proceedings. This can be particularly relevant for entities threatened with or sued for patent infringement[2].

Policy and Regulatory Implications

Innovation and Regulation

  • Patents are a valuable indicator of the pace and dynamics of innovation. Empirical studies on patenting activity can inform policy proposals related to intellectual property rights (IPRs) and regulation. The analysis of patent claims and the patent landscape can help in assessing the impact of regulatory changes on innovation[3].

Criticisms and Challenges

  • The PTAB has been criticized for making it too easy to challenge patents, which can create uncertainty in patent rights and potentially stifle innovation. However, the intent behind PTAB is to improve patent quality and reduce unwarranted litigation costs[2].

Key Takeaways

  • Patent Components: A patent includes a cover page, abstract, drawings, specification, and patent claims, each serving a critical role in defining the invention.
  • Legal Requirements: The invention must meet the requirements of written description, enablement, novelty, and nonobviousness to be patentable.
  • Claims Analysis: Carefully reviewing the patent claims is essential to understand the scope of the patent right.
  • Patent Landscape: Analyzing the geographical distribution, technological milestones, and competitive intelligence can provide valuable insights into the innovation landscape.
  • Enforcement and Litigation: Understanding the mechanisms for enforcing patents and challenging their validity is crucial for navigating the patent system.

FAQs

Q: What are the key components of a patent?

A: The key components include the cover page, abstract, drawings, specification, and patent claims.

Q: What is the purpose of the specification in a patent?

A: The specification must adequately describe the invention, enabling a person skilled in the relevant technology to make and use the invention.

Q: How does the PTAB impact patent litigation?

A: The PTAB provides a faster and less expensive way to challenge patent validity, which can be advantageous for entities facing patent infringement claims.

Q: Why is prior art analysis important in patent prosecution?

A: Prior art analysis helps determine whether the claimed invention is novel and nonobvious, and it informs the examiner’s decisions during the patent prosecution process.

Q: How can patent file wrappers be used for competitive intelligence?

A: Patent file wrappers provide insights into the arguments made by examiners and the strategies employed by applicants, which can be crucial for investment decisions and understanding the competitive landscape.

Sources

  1. Congressional Research Service, "Patent Law: A Handbook for Congress" (2020).
  2. Congressional Research Service, "The Patent Trial and Appeal Board and Inter Partes Review" (2023).
  3. Stanford Center for Responsible Quantum Technology, "Quantum Leap: Decoding Quantum Computing Innovation" (n.d.).
  4. LexisNexis IP, "Patent Analysis Tools for Objective Application Review" (2021).
  5. IP Checkups, "Patent file wrappers as a tool for competitive intelligence" (2023).

More… ↓

⤷  Try for Free

Details for Patent 10,155,932

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Glaxosmithkline Biologicals FLUARIX, FLUARIX QUADRIVALENT influenza vaccine Injection 125127 August 31, 2005 10,155,932 2036-05-09
Glaxosmithkline Biologicals FLUARIX, FLUARIX QUADRIVALENT influenza vaccine Injection 125127 December 14, 2012 10,155,932 2036-05-09
Id Biomedical Corporation Of Quebec FLULAVAL, FLULAVAL QUADRIVALENT influenza vaccine Injection 125163 October 05, 2006 10,155,932 2036-05-09
Id Biomedical Corporation Of Quebec FLULAVAL, FLULAVAL QUADRIVALENT influenza vaccine Injection 125163 November 10, 2009 10,155,932 2036-05-09
Id Biomedical Corporation Of Quebec FLULAVAL, FLULAVAL QUADRIVALENT influenza vaccine Injection 125163 August 15, 2013 10,155,932 2036-05-09
Id Biomedical Corporation Of Quebec FLULAVAL, FLULAVAL QUADRIVALENT influenza vaccine Injection 125163 September 27, 2013 10,155,932 2036-05-09
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.